EUVIMEDEUVIMED entdecken
Open Access

Retraction: Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway

Tiantian Wang, Mei Wang, Shuang Fang, Qiang Wang, Rui Fang, Jie Chen

Oncotarget · 06.01.2026 · 17 (1) · 180-181

DOI: 10.18632/oncotarget.28833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, erschienen am 06.01.2026. Verfasst von Tiantian Wang und 5 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wang, T., Wang, M., Fang, S., Wang, Q., Fang, R., & Chen, J. (2026). Retraction: Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway. Oncotarget, 17(1), 180-181. https://doi.org/10.18632/oncotarget.28833

Vancouver

Wang T, Wang M, Fang S, Wang Q, Fang R, Chen J. Retraction: Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway. Oncotarget. 2026;17(1):180-181. doi:10.18632/oncotarget.28833

BibTeX
@article{Wang2026,
  author = {Wang, Tiantian and Wang, Mei and Fang, Shuang and Wang, Qiang and Fang, Rui and Chen, Jie},
  title = {Retraction: Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway},
  journal = {Oncotarget},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {180--181},
  doi = {10.18632/oncotarget.28833}
}
Kostenlos starten →